Loading insider details...
Beta
Latest Form 4 (Jun 24, 2026): Sale of 5,696 ARVN shares, $46.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | ARVINAS, INC. (ARVN) | Sale | 5,696 | $46.5K |
| Jun 12, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 77,000 | n/a |
| May 13, 2026 | ARVINAS, INC. (ARVN) | Sale | 11,139 | $110.7K |
| Mar 3, 2026 | ARVINAS, INC. (ARVN) | Grant/Award | 45,000 | n/a |
| Feb 18, 2026 | ARVINAS, INC. (ARVN) | Sale | 5,134 | $61.0K |
| Jun 24, 2025 | ARVINAS, INC. (ARVN) | Sale | 5,700 | $43.4K |
| Jun 12, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 40,000 | n/a |
| May 13, 2025 | ARVINAS, INC. (ARVN) | Grant/Award | 59,600 | n/a |
| Feb 19, 2025 | ARVINAS, INC. (ARVN) | Grant/Award | 49,092 | n/a |
| Aug 29, 2024 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 40,000 | n/a |